We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sdi Group Plc | LSE:SDI | London | Ordinary Share | GB00B3FBWW43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.60 | -2.88% | 54.00 | 54.00 | 55.00 | 55.50 | 54.50 | 55.50 | 378,275 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 67.58M | 3.87M | 0.0372 | 14.65 | 56.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/5/2017 21:41 | That article is seriously out of date. The use of satellite navigation systems along with detailed production data to accurately dose fertiliser as the tractor moves around the field was developed years ago. | this_is_me | |
28/4/2017 09:37 | Beyond 26 this surpasses its 5 year high. It's been one great bowl so far. | brucie5 | |
27/4/2017 12:19 | News: "Thursday 27th April 2017 NEW fluorescent peptide imaging application of PXi imaging system Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce its PXi multi-application imager is being used by scientists at the prestigious Freie Universtät Berlin for the new application of imaging fluorescent peptides on Western blots. Using the system is providing the researchers with a simple, sensitive method to detect cancer-linked transcription factors. In the Institute for Pharmacy at the Freie Universtät Berlin in Germany, scientists are using the PXi imaging system fitted with a 4 million pixel CCD camera, for imaging a peptide labelled with 5-carboxyfluorescein to fish out key interacting protein partners to essential transcription factors on Western blots. This drug discovery research may contribute to finding druggable targets for treating leukaemia and other life threatening cancers. Ee Lin Wong, a Ph.D. student in the Department of Pharmacy explained: “We work with a fluorescent peptide on Western blots but we can’t image our results using X-ray film because the fluorescence with this peptide can get so bright that it causes band saturation which over-exposes the film and ruins the results. Then we must start all over again with new film, which takes time and is frustrating.” Ee Lin added: “We chose the PXi because the system is compact, yet is more sensitive than film. This saves time as we can detect the proteins we’re looking for without having to keep repeating our fluorescent blots or use extra X-ray film. The best thing about the PXi is that the software is very fast and downloads images we can save to a USB stick in a format we can easily analyse and transfer into a file at exactly the right specifications for publication. This allows us to submit good quality figures more rapidly to scientific journals and is a great feature of the PXi system.” To find out more about the fluorescence imaging capabilities of the multi-functional PXi system, please click here: hxxp://www.syngene.c “We’re always pleased to hear about new and exciting applications of our imaging technology,” stated Dr Martin Biggs, Sales Manager at Syngene. “The research at this prestigious German institute shows that the PXi imaging system is an excellent choice for drug discovery scientists looking to access sensitive detection of fluorescent peptides, as well as quickly and easily generate publication-quality formats of their important scientific data." | rivaldo | |
15/4/2017 20:12 | looks like breakout coming here on chart | onjohn | |
07/4/2017 07:40 | Nice spot rivaldo. | hastings | |
07/4/2017 07:26 | SDI introduce "revolutionary" new software (ThermoFisher are huge, with $17 billion+ turnover): "Wednesday 5th April 2017 Synbiosis introduces ThermoFisher Scientific Chromogenic ID Media Software Cambridge, UK: Synbiosis, a long-established, expert manufacturer of automated microbiological systems, is delighted to announce its Chromogenic ID software for use with Synbiosis colony counters now has a validated module for automatic identification of bacteria and yeasts on ThermoFisher Scientific’s Oxoid Chromogenic media. Using this revolutionary software allows microbiologists to rapidly and accurately identify microbes cultured on the world’s most commonly used media. The intuitive Chromogenic ID software module, guarantees that microbiologists using the digital colour imaging technology unique to the ChromoZona, ProtoCOL 3, and Protos 3 systems can with minimal training, automate precise identification of microorganisms on the Brilliance™ Candida, CRE and UTI ranges of ThermoFisher Scientific’s Oxoid chromogenic media. This not only saves time but also ensures that results are objective and consistent between scientists. By analysing true to life colour plate images captured by ChromoZona, ProtoCOL 3 and Protos 3 systems, the software’s advanced algorithms can distinguish between similar shades of mauve, pink and blue colonies. This provides fast identification of microbes including Candida spp., carbapenem-resistant E. coli, Klebsiella spp., Enterobacter spp., Serratia spp., Citrobacter spp. Enterococcus spp., Proteus, Morganella and Providencia spp. on four different Brilliance agar plate types. By collecting consistent data and reducing identification errors, the new Chromogenic ID software generates accurate results every time. These can be stored in a secure SQL database, making the software compliant with CFR 21 part 11 and easier to integrate into a GLP/GMP environment. To find out more about this innovative new Oxoid Chromogenic ID Media Software Module scientists can click the link: hxxp://www.synbiosis “Oxoid’s chromogenic media is extensively used world-wide, yet distinguishing between different coloured colonies on these media can be problematic and depends on the subjective colour vision of the scientist” explains Kate George, Senior Divisional Manager at Synbiosis. “Utilising our incredible new software module to automatically analyse these well-known plates is a major advance which guarantees microbiologists everywhere efficient and accurate microbial identification.&rdqu | rivaldo | |
04/4/2017 13:33 | Have been adding during this weakness. | aishah | |
03/4/2017 12:08 | Ignore it - actual trades are often well inside the published spread, as proven this morning. | rivaldo | |
03/4/2017 11:14 | Spread appears high | essential | |
03/4/2017 10:52 | Unusually active this morning, with 10 straight buys including a 40k buy at 24.99p. | rivaldo | |
28/3/2017 13:31 | Good to see ProReveal getting good exposure at the recent Theatres & Decontamination Conference - in a prominent morning slot too! "9:30 Pro Reveal System, Professor David Perrett, Professor of BioAnalytical Science, Barts & The London School of Medicine 10:00 An Introduction to the ProReveal Protein Detection System & Compliance to the Updated HTM01:01, Matthew Peskett, Managing Director, Peskett Solutions Ltd" | rivaldo | |
23/3/2017 09:00 | News from Syngene: "Tuesday 21st March 2017 G:BOX Chemi XX6 used to study effects of stressors on bacteria - research may contribute to identifying targets for new anti-microbials Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce its G:BOX Chemi XX6 multi-application imager is being utilised by scientists at the University of Warwick to rapidly and accurately analyse how Gram positive bacteria react to stressors. This is providing information on phenotypic changes and may identify potential genetic targets, which could help in developing new anti-microbial therapies for drug-resistant bacteria. Researchers in the Department of Biomedical Sciences at the University of Warwick are using a G:BOX Chemi XX6 multi-application imaging system to study the changes that occur following exposure to stressors in the model Gram positive bacteria, Bacillus subtilis (a close relative of drug-resistant bacteria, such as Staphylococcus aureus).... ....Dr Emma Denham, Assistant Professor of Molecular Bacteriology at the University of Warwick explained: “B. subtilis expresses over 1500 non-coding RNAs and we want to determine what they are regulating and how they are doing it. As part of this research we’re using a G:BOX Chemi XX6 system to analyse chemiluminescent RNA and proteins, as well as image B. subtilis and E. coli colonies on 25 cm plates to identify interesting clones.” Emma continued: “We chose the G:BOX Chemi XX6 because it is the only analyser we tested that could cope with imaging bacteria on large plates, as well as Northern and Western blots and we haven’t yet found a fluorescence or chemi imaging application the G:BOX Chemi XX6 cannot perform.” | rivaldo | |
17/3/2017 16:32 | The bid is wrong at 23p as I can sell £10k worth for 24,333p | malcolmmm | |
16/3/2017 11:25 | A nice bullish flag is forming ready for the next push north | essential | |
16/3/2017 07:58 | Another interpretation as that normally a fairly illiquid stock so took advantage of the liquidity event to avoid depressing the price. The big question could be "are they still potential sellers" ? | pugugly | |
16/3/2017 07:53 | Not totally surprising, leaves something for the next man. | hastings | |
16/3/2017 07:37 | Interesting that ORYX INTERNATIONAL GROWTH FUND LIMITED taken advatage of the spike opportunity to reduce holding to 6.34% from above 7% | pugugly | |
14/3/2017 18:24 | Worth recapping on the rather impressive shareholder list and percentage holdings for one that although growing, at present remains small. Business Growth Fund 12.12 Harwood Capital 9.39 Octopus Investments 8.67 Herald Investment Management 8.54 Milton Asset Management 7.78 Individuals 5.85 Hargreave Hale, stockbrokers (ND) 4.95 Charles Stanley 4.03 Dana Investments BV 3.94 | hastings | |
14/3/2017 16:26 | Yes mostly buys today for the second day running, they seem reluctant to move the price up. | malcolmmm | |
14/3/2017 08:10 | Just topped up and showing as a sell | essential | |
13/3/2017 22:45 | Or even filled I mean | johnv | |
13/3/2017 22:43 | Whopping gap between 20 and 23.5p, will it be closed? | johnv | |
12/3/2017 13:41 | Chart looks good for breakout🌷 | opodio | |
10/3/2017 11:36 | Rivaldo, not included at present, but one would assume an obvious route for the future.I think that aside, SDI has plenty to be going at, with ATIK continuing to perform strongly, the new businesses already delivering and the looming deadline for the NHS to act around the instrumentation space, firstly in Neurology.Oh and then I'm sure we will have another acquisition before the year is out.Happy holder. | hastings |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions